Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

316 Press Releases
DateTitleCompany
23 Apr 15 Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS Teva Pharmaceutical Industries Ltd. and Active Biotech,
Published by
Business Wire
23 Apr 15 Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C. Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Apr 15 Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Apr 15 Teva to Report First Quarter 2015 Financial Results on April 30 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Apr 15 Teva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for Filing Teva Pharmaceutical Industries Ltd. and Eagle Pharmaceuticals, Inc.,
Published by
Business Wire
13 Apr 15 Teva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C. Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Apr 15 Teva and Xenon Announce Enrollment of First Patient in a Phase 2b Study Evaluating TV-45070 for Postherpetic Neuralgia (PHN) Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Apr 15 Teva Announces FDA Approval of ProAir® RespiClick Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Mar 15 Teva Expands Hypertension Line with Launch of Generic Exforge® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Mar 15 Teva Announces New Head of Business Development Strategy and Innovation Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Mar 15 Teva’s TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study Demonstrating Treatment Concept After a Single Dose Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Mar 15 Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Mar 15 Teva to Present at the Barclays Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Mar 15 Teva Announces Sale of Sellersville PA Facility Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Feb 15 Teva Announces Early Results of Debt Tender Offer Pricing Election of Early Settlement and Increase in Maximum Amount and Priority 2 Notes Tender Cap Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Feb 15 Teva to Present at the Cowen & Company 35th Annual Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Feb 15 Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion Product Teva Pharmaceutical Industries Ltd.
10 Feb 15 Teva Files 2014 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Feb 15 Teva Thanks Dr. Phillip Frost for Board Service Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Jan 15 Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Jan 15 Teva to Report Fourth Quarter 2014 Financial Results on February 5 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Jan 15 Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 15 Teva Launches Generic Diovan® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Dec 14 Teva Announces Launch of First Generic Celebrex® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 14 Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Dec 14 Teva Announces Launch of Generic Exforge HCT® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Oct 14 Teva to Report Third Quarter 2014 Financial Results on October 30 2014 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
04 Sep 14 Teva Announces Launch of Generic Baraclude® Tablets 0.5mg and 1mg in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Sep 14 Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Aug 14 Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.